Michael Peoples

2.9k total citations
16 papers, 267 citations indexed

About

Michael Peoples is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Michael Peoples has authored 16 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Michael Peoples's work include Chronic Lymphocytic Leukemia Research (3 papers), Epigenetics and DNA Methylation (3 papers) and Animal Genetics and Reproduction (3 papers). Michael Peoples is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Epigenetics and DNA Methylation (3 papers) and Animal Genetics and Reproduction (3 papers). Michael Peoples collaborates with scholars based in United States, Italy and Canada. Michael Peoples's co-authors include Christopher A. Bristow, Alessandro Carugo, Jared J. Fradette, Rosalba Minelli, Don L. Gibbons, Timothy P. Heffernan, Charles R. Long, David H. Peng, Mark Westhusin and Jeffrey J. Kovacs and has published in prestigious journals such as Nature Communications, Cancer Research and Oncogene.

In The Last Decade

Michael Peoples

13 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Peoples United States 9 181 105 59 36 35 16 267
Trevor G. Levin United States 6 147 0.8× 189 1.8× 74 1.3× 30 0.8× 35 1.0× 15 314
Rebecca F. Rogers Australia 6 132 0.7× 74 0.7× 68 1.2× 23 0.6× 30 0.9× 6 212
Marianna Buttarelli Italy 13 179 1.0× 129 1.2× 88 1.5× 37 1.0× 38 1.1× 19 320
C Ludwig United States 6 215 1.2× 86 0.8× 72 1.2× 45 1.3× 65 1.9× 8 318
Lilia Merida de Long Australia 9 225 1.2× 115 1.1× 69 1.2× 50 1.4× 21 0.6× 16 317
Juri Na South Korea 8 148 0.8× 46 0.4× 72 1.2× 18 0.5× 74 2.1× 15 276
Anne-Catherine Jallas France 6 196 1.1× 186 1.8× 77 1.3× 31 0.9× 52 1.5× 8 331
Susan K. Rathe United States 12 234 1.3× 100 1.0× 84 1.4× 67 1.9× 87 2.5× 18 390
Titia G. Meijer Netherlands 7 119 0.7× 196 1.9× 55 0.9× 38 1.1× 26 0.7× 10 291
Jung‐Min Lee United States 8 171 0.9× 123 1.2× 60 1.0× 15 0.4× 51 1.5× 16 277

Countries citing papers authored by Michael Peoples

Since Specialization
Citations

This map shows the geographic impact of Michael Peoples's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Peoples with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Peoples more than expected).

Fields of papers citing papers by Michael Peoples

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Peoples. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Peoples. The network helps show where Michael Peoples may publish in the future.

Co-authorship network of co-authors of Michael Peoples

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Peoples. A scholar is included among the top collaborators of Michael Peoples based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Peoples. Michael Peoples is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Morris, Van K., Stefania Napolitano, Christopher A. Bristow, et al.. (2024). Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation as a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer. Clinical Cancer Research. 30(22). 5166–5179. 7 indexed citations
2.
Wong, Chi Wut, Rosalba Minelli, Michael Peoples, et al.. (2024). Abstract 3280: ASCL2+ tumor cells modulate the response of colorectal cancer to MAPK targeting therapy. Cancer Research. 84(6_Supplement). 3280–3280.
3.
Shariati, Maryam, Kurt W. Evans, Xiaofeng Zheng, et al.. (2021). Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations. Oncogene. 40(26). 4425–4439. 17 indexed citations
4.
Konen, Jessica, B. Leticia Rodriguez, Jared J. Fradette, et al.. (2021). Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancer. JCI Insight. 6(17). 14 indexed citations
5.
Punzi, Simona, Consalvo Petti, Rosalba Minelli, et al.. (2021). Synthetic Lethality Screening Highlights Colorectal Cancer Vulnerability to Concomitant Blockade of NEDD8 and EGFR Pathways. Cancers. 13(15). 3805–3805. 10 indexed citations
6.
Aslan, Burcu, Görkem Kısmalı, Lisa S. Chen, et al.. (2021). Development and characterization of prototypes for in vitro and in vivo mouse models of ibrutinib-resistant CLL. Blood Advances. 5(16). 3134–3146. 6 indexed citations
7.
Coyaud, Étienne, Samrat T. Kundu, David H. Peng, et al.. (2019). ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancer. Nature Communications. 10(1). 5125–5125. 73 indexed citations
8.
Aslan, Burcu, Mikhila Mahendra, Michael Peoples, et al.. (2019). Abstract 317: Vecabrutinib inhibits C481 mutated Bruton's tyrosine kinase and its downstream signaling in vitro. 317–317. 1 indexed citations
9.
Konen, Jessica, B. Leticia Rodriguez, Jared J. Fradette, et al.. (2019). Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung Cancer. Cancers. 11(4). 462–462. 24 indexed citations
10.
Peng, David H., Samrat T. Kundu, Jared J. Fradette, et al.. (2019). ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism. Science Translational Medicine. 11(483). 39 indexed citations
11.
Powell, Emily, Jiansu Shao, Christopher A. Bristow, et al.. (2018). A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasis. npj Breast Cancer. 4(1). 9–9. 39 indexed citations
12.
Xie, Tongxin, Liang Yang, Jiping Wang, et al.. (2017). Abstract IA12: An in vivo high throughput shRNA screening platform for identifying ways to target genomic alterations. Clinical Cancer Research. 23(23_Supplement). IA12–IA12.
13.
Golding, Michael C., Matthew Snyder, Kylee J. Veazey, et al.. (2015). Histone-lysine N-methyltransferase SETDB1 is required for development of the bovine blastocyst. Theriogenology. 84(8). 1411–1422. 11 indexed citations
14.
Snyder, Matthew, J. H. Pryor, Michael Peoples, et al.. (2013). 122 SUPPRESSION OF EPIGENETIC MODIFIERS ALTERS THE BOVINE EMBRYONIC DEVELOPMENTAL PROGRAM DURING IN VITRO CULTURE. Reproduction Fertility and Development. 26(1). 175–175. 1 indexed citations
15.
Golding, Michael C., et al.. (2011). Production of transgenic calves expressing an shRNA targeting myostatin. Molecular Reproduction and Development. 79(3). 176–185. 25 indexed citations
16.
Bormann, Charles L., et al.. (2008). 189 TRANSCRIPTIONAL PROFILING OF HISTONE-MODIFYING GENES DURING BOVINE PRE-IMPLANTATION EMBRYO DEVELOPMENT IN VITRO. Reproduction Fertility and Development. 21(1). 193–193.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Trevor G. Levin Breakdown of academic impact, for papers by Rebecca F. Rogers Breakdown of academic impact, for papers by Marianna Buttarelli Breakdown of academic impact, for papers by C Ludwig Breakdown of academic impact, for papers by Lilia Merida de Long Breakdown of academic impact, for papers by Juri Na Breakdown of academic impact, for papers by Anne-Catherine Jallas Breakdown of academic impact, for papers by Susan K. Rathe Breakdown of academic impact, for papers by Titia G. Meijer Breakdown of academic impact, for papers by Jung‐Min Lee
Rankless by CCL
2026